Gastroesophageal Reflux Disease Market Share

North American Market Forecast

North America industry is predicted to dominate majority revenue share of 35% by 2037. The primary factor for the market expansion is the rising aging population in the region which are more prone to gastrointestinal problems. Furthermore, the rising awareness regarding drug therapies along with the high rate of acceptance of therapy for GERD diseases is also estimated to bring growth opportunities for market expansion in the region.

APAC Market Analysis

The Asia Pacific gastroesophageal reflux disease market is estimated to grow at a notable pace and holds almost 24% market share by the end of the forecast timeline. The rising awareness about health and fitness among the people in the region and the increase in health spending is considered to be the major factor for market growth in the region during the next years. In addition, the expenditure on healthcare from foreign countries is increasing which is favoring the new drug development for GERD treatment in the region.